Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06420687 · ClinicalTrials.gov registry record · NA

GaMA Metric to Quantify Functional Importance of Various Upper Limb Prosthetic Devices

A NA study of Amputation and Amputation, Traumatic, sponsored by Shirley Ryan AbilityLab.

Active
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT06420687: Active NA study of Amputation and Amputation, Traumatic, sponsored by Shirley Ryan AbilityLab.

NCT06420687 is a NA study of Amputation and Amputation, Traumatic that is active but no longer recruiting, run by Shirley Ryan AbilityLab. The registered enrollment target is 45 participants, below the 132-participant average among 65 other Amputation trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06420687, a NA study of Amputation and Amputation, Traumatic, is active but no longer recruiting, sponsored by Shirley Ryan AbilityLab.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to utilize the Gaze and Movement Assessment (GaMA) metric to assess the effect of different prosthetic components on compensatory movements used to complete activities of daily living.

Primary Outcome

Utilizes motion capture hardware during prosthesis use and collects three dimensional angular kinematics, gaze behavior and performance during simulated tasks. Participants move a pasta box from the target on a side cart at the right side of the body onto a mid-height shelf target in front of them. Then they move the box from the mid-height shelf target to the high shelf target on the opposite side. Finally, they pick up the pasta box from the high shelf target and return it to the initial posi

Interventions

  • DEVICE Clinically prescribed prosthesis
  • DEVICE Experimental prosthesis - Wrist rotation + 1-DOF
  • DEVICE Experimental prosthesis - Wrist rotation + Wrist flexion +1-DOF
  • DEVICE Experimental prosthesis - Wrist rotation + Multi DOF hand
  • DEVICE Experimental prosthesis - Wrist rotation + wrist flexion + Multi DOF hand

Study Locations (1)

Illinois

  • Shirley Ryan AbilityLab - Chicago

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2020-04-20
Est. Completion 2025-09
Phase NA
Shirley Ryan AbilityLab

138 total trials

What the registry record for NCT06420687 still lists

NCT06420687 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 132-participant average among 65 other Amputation trials with a reported enrollment target (66% lower).

The record links to 4 conditions, with Amputation appearing as the primary indexed condition, and to 5 interventions - of which Clinically prescribed prosthesis is the first listed.

NCT06420687 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT06420687 about?

NCT06420687 is a clinical study titled "GaMA Metric to Quantify Functional Importance of Various Upper Limb Prosthetic Devices". The goal of this study is to utilize the Gaze and Movement Assessment (GaMA) metric to assess the effect of different prosthetic components on compensatory movements used to complete activities of daily living.

What is the current status of trial NCT06420687?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2020-04-20. Estimated completion is 2025-09.

What conditions does trial NCT06420687 study?

This clinical trial studies the following conditions: Amputation, Amputation, Traumatic, Amputation; Traumatic, Hand, Amputation; Traumatic, Limb.

What interventions are being tested in trial NCT06420687?

The interventions under investigation include: Clinically prescribed prosthesis (DEVICE), Experimental prosthesis - Wrist rotation + 1-DOF (DEVICE), Experimental prosthesis - Wrist rotation + Wrist flexion +1-DOF (DEVICE), Experimental prosthesis - Wrist rotation + Multi DOF hand (DEVICE), Experimental prosthesis - Wrist rotation + wrist flexion + Multi DOF hand (DEVICE).

Who is sponsoring clinical trial NCT06420687?

This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06420687 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amputation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06420687's enrollment target sits among peer trials

45 20th of 65 higher than 45 of 65 other Amputation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Amputation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00804154 · 45 participants · Phase 1

    Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

  • NCT01851694 · 45 participants · NA

    Beta-cell Response to Incretin Hormones in Cystic Fibrosis

  • NCT02896335 · 45 participants · Phase 2

    Palbociclib and Pembrolizumab In Central Nervous System Metastases

  • NCT03454035 · 45 participants · Phase 1

    Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06420687, the US trial registry maintained by the National Library of Medicine. NCT06420687 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.